EXPRS2 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. Its products and services include custom made proteins and reagents; transfection reagent; process development; feasibility studies; and licensing. The company was founded by Charlotte Dyring, Wian de Jongh, and Martin Roland Jensen in 2010 and is headquartered in Hørsholm, Denmark.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
EXPRS2 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company